Kieran Moynihan

Mirai Medical Ltd. is an Irish medical technology company that focuses on improving cancer outcomes and enhancing patient experiences. The company is based in Oranmore, Ireland. Mirai Medical has developed a unique precision therapy platform called epore® technology, which targets tumour tissue while preserving surrounding healthy tissue structure. This technique greatly reduces side effects and improves the experience of cancer patients. Mirai Medical's epore® and endove® therapies are approved for commercialization in certain countries and are designed to provide safe and highly effective treatment of skin and gastrointestinal cancers. The company was founded in 2015 by Declan Soden, who has been the CEO since then.

Mirai Medical Ltd. is an Irish medical technology company that focuses on improving cancer outcomes and enhancing patient experiences. The company is based in Oranmore, Ireland. Mirai Medical has developed a unique precision therapy platform called epore® technology, which targets tumour tissue while preserving surrounding healthy tissue structure. This technique greatly reduces side effects and improves the experience of cancer patients. Mirai Medical's epore® and endove® therapies are approved for commercialization in certain countries and are designed to provide safe and highly effective treatment of skin and gastrointestinal cancers. The company was founded in 2015 by Declan Soden, who has been the CEO since then.

Mirai Medical Ltd. is an Irish medical technology company that focuses on improving cancer outcomes and enhancing patient experiences. The company is based in Oranmore, Ireland. Mirai Medical has developed a unique precision therapy platform called epore® technology, which targets tumour tissue while preserving surrounding healthy tissue structure. This technique greatly reduces side effects and improves the experience of cancer patients. Mirai Medical's epore® and endove® therapies are approved for commercialization in certain countries and are designed to provide safe and highly effective treatment of skin and gastrointestinal cancers. The company was founded in 2015 by Declan Soden, who has been the CEO since then.

Mirai Medical Ltd. is an Irish medical technology company that focuses on improving cancer outcomes and enhancing patient experiences. The company is based in Oranmore, Ireland. Mirai Medical has developed a unique precision therapy platform called epore® technology, which targets tumour tissue while preserving surrounding healthy tissue structure. This technique greatly reduces side effects and improves the experience of cancer patients. Mirai Medical's epore® and endove® therapies are approved for commercialization in certain countries and are designed to provide safe and highly effective treatment of skin and gastrointestinal cancers. The company was founded in 2015 by Declan Soden, who has been the CEO since then.

Mirai Medical Ltd. is an Irish medical technology company that focuses on improving cancer outcomes and enhancing patient experiences. The company is based in Oranmore, Ireland. Mirai Medical has developed a unique precision therapy platform called epore® technology, which targets tumour tissue while preserving surrounding healthy tissue structure. This technique greatly reduces side effects and improves the experience of cancer patients. Mirai Medical's epore® and endove® therapies are approved for commercialization in certain countries and are designed to provide safe and highly effective treatment of skin and gastrointestinal cancers. The company was founded in 2015 by Declan Soden, who has been the CEO since then.